• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HYALURONIC ACID SYRINGE PEN; PEN INJECTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HYALURONIC ACID SYRINGE PEN; PEN INJECTOR Back to Search Results
Lot Number 0220210415
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Date 04/19/2021
Event Type  Injury  
Event Description
Lipo lab ppc solution ((b)(4) product): phosphatidycholine, deoxycholate.Yipner (made in (b)(4)).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYALURONIC ACID SYRINGE PEN
Type of Device
PEN INJECTOR
MDR Report Key12138072
MDR Text Key260877300
Report NumberMW5102398
Device Sequence Number1
Product Code NSC
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 07/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date04/14/2021
Device Lot Number0220210415
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age24 YR
Patient Weight66
-
-